LONGARINI, RAFFAELLA

LONGARINI, RAFFAELLA  

Universita' degli Studi di MILANO  

Risultati 1 - 5 di 5 (tempo di esecuzione: 0.166 secondi).
Titolo Data di pubblicazione Autore(i) Tipo File Abstract
Capecitabine and Temozolomide versus FOLFIRI in RAS-Mutated, MGMT-Methylated Metastatic Colorectal Cancer 1-gen-2019 Pietrantonio, FilippoLobefaro, RiccardoRaimondi, AlessandraSartore-Bianchi, AndreaLongarini, RaffaellaPetrelli, FaustoRandon, GiovanniPagani, FilippoFucà, Giovannide Braud, Filippo + Article (author) -
Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with panitumumab-based first-line treatment strategy : A pre-specified secondary analysis of the Valentino study 1-ago-2020 Raimondi ASartore-Bianchi ALongarini RPeverelli Gde Braud FPietrantonio F. + Article (author) -
Maintenance Therapy with Panitumumab Alone vs Panitumumab Plus Fluorouracil-Leucovorin in Patients with RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial 1-set-2019 Pietrantonio, FilippoRaimondi, AlessandraSartore-Bianchi, AndreaNiger, MonicaPetrelli, FaustoLongarini, RaffaellaDi Bartolomeo, Mariade Braud, Filippo + Article (author) -
Single-agent panitumumab in frail elderly patients with advanced RAS and BRAF wild-type colorectal cancer : challenging drug label to light up new hope 1-nov-2015 F. PietrantonioA. MennittoR. LongariniM. Di BartolomeoF. De Braud + Article (author) -
Systemic doxycycline for pre-emptive treatment of anti-EGFR-related skin toxicity in patients with metastatic colorectal cancer receiving first-line panitumumab-based therapy: a post hoc analysis of the Valentino study 1-gen-2021 Corallo S.Toscano G.Tomasello G.Petrelli F.Longarini R.Niger M.Prisciandaro M.Randon G.de Braud F.Di Bartolomeo M.Pietrantonio F. + Article (author) -